Normal acuity, no RAPD or an unremarkable fundus cannot individually exclude serious disease. Select the next test for the clinical question and urgency.
Terminology and draft status
Terminology review is not complete. Selected actual WHO UMD queries and their limits are recorded in terminology.md; they do not approve the whole translation.
01Triage first, then examine systematically
History, examination, differential diagnosis and targeted investigations form a connected sequence. The lecture’s jigsaw-puzzle and old-car/Ferrari analogies illustrate fundamental clinical skills across different resources, not diagnostic infallibility or superiority of one specialty. 14
Sudden visual loss, new field loss, suspected giant cell arteritis (GCA), stroke or papilloedema require urgent pathways. Do not complete a rigid routine checklist before arranging time-critical assessment; normal acuity or an unremarkable fundus does not establish safety. 3 9 10
The five examination pillars are visual acuity, colour, pupils, optic disc and visual fields. Integrate them with symptoms and course; each can reveal a deficit that another misses, and no single normal result ends the assessment. 14
02Localise with history and exposures
Ask about age, laterality and tempo. The source compares ages 20–40 with over 60 as a clue to inflammatory versus vascular disease, not a diagnostic rule; acute minutes/hours, subacute days/weeks and chronic months/years overlap. Unilateral loss suggests a pre-chiasmal problem, while bilateral loss can arise from either both eyes/nerves or the chiasmal/post-chiasmal pathway. 14
Jaw claudication, temporal headache, weight loss and night sweats raise GCA concern; facial numbness, speech difficulty or weakness may indicate stroke. Pain on eye movement, paraesthesia or focal weakness can suggest inflammatory/demyelinating disease; proptosis, diplopia or reduced facial sensation require orbital assessment. Weight gain, pulsatile tinnitus and headache on bending suggest raised pressure without proving idiopathic intracranial hypertension (IIH). 3 9 10
Record amblyopia/patching, surgery, trauma and refractive procedures with possible late corneal ectasia. Ask about hypertension, diabetes, lipids, multiple sclerosis (MS), autoimmune disease, tuberculosis and sarcoidosis; a previous diagnosis may confound but does not explain every new symptom. 14
Ask neutrally about occupation, restrictive or vegan diets, vitamin B12 or vitamin A deficiency risk, alcohol, tobacco and all medicines. These do not establish inevitable toxic neuropathy; nutritional problems may affect retina or nerve, and occupational access to dilating agents, for example in nursing, does not establish use or intent. The medication table separates toxic, pressure-related and vascular associations without prescribing a dose. 3 5 14
Discuss driving with the appropriate jurisdiction. In the UK, the driver has a duty to notify the licensing authority when relevant standards are not met; GMC guidance sets conditions for clinician disclosure when unsafe driving continues. The original blanket claim of automatic physician reporting for every relevant field defect is too broad and is not German legal advice. 15 16
| Category | Question and clinical meaning |
|---|---|
| Age | 20–40 versus over60 is a differential clue, not exclusion. |
| Laterality | Unilateral pre-chiasmal; bilateral can be ocular, optic-nerve, chiasmal or post-chiasmal. |
| Onset | Acute minutes/hours, subacute days/weeks, chronic months/years; vascular, inflammatory and compressive causes overlap. |
| Associated symptoms | GCA/systemic, stroke/MS, raised-pressure and orbital symptoms; urgency and cause require assessment. |
| Past history | Ocular amblyopia/patching, surgery, trauma, refractive ectasia; medical HTN, diabetes, lipids, MS, autoimmune disease, TB and sarcoid. |
| Social history | Jurisdiction-specific driving advice; occupation/dilating-agent exposure; restrictive diet and B12/A; alcohol/tobacco without automatic causality. |
| Medication | Association and limit |
|---|---|
| Anti-tuberculosis drugs | Ethambutol can cause toxic optic neuropathy; not all agents are equivalent. |
| Systemic corticosteroids | Withdrawal can be associated with raised pressure; not every exposure proves idiopathic IIH. |
| Doxycycline | Association with intracranial hypertension; evaluate secondary/drug-related causes. |
| Sildenafil (Viagra), semaglutide (Wegovy) | NAION concern: sildenafil association is not universal causality; EMA2025 calls semaglutide NAION very rare. Communication differs from current label verification. |
| Barbiturates | Can be associated with nystagmus; record exposure and assess the full clinical context. |
03Measure acuity and colour without blanket test claims
Test each eye separately with and without correction and with a pinhole; record Snellen or logMAR and testing conditions. Good acuity does not exclude significant field loss or disc disease. Ishihara mainly tests red–green discrimination; an acquired colour deficit or red desaturation can support afferent disease but does not identify its cause alone. 14
Mobile colour tests require their own validation. A study of 77 people using an iPhone 8 Plus reported AUC 0.812/0.778 for two apps versus 0.736 for Ishihara, without a significant difference; another study of 42 normal and 38 colour-deficient participants found 100% sensitivity but specificity 95.2% versus 54.8% for two apps. Nonsignificance is not equivalence, and agreement with a booklet is not validation for every acquired optic neuropathy. 11 12 13
A selected iPad optic-neuritis abstract gives no sample size or accuracy estimate; no numbers are inferred. The earlier related lecture’s 6/18 colour-test threshold and acquired-random/congenital-predictable error rule remain unverified and are not applied to this patient pathway. 11 12 13
04Interpret RAPD as relative afferent asymmetry
Inspect pupil size, shape and symmetry in light and dark; use distant fixation, a darkened room, examiner at eye level and comparable bright illumination. The source describes direct/consensual response over 2–3 seconds per eye and a switch within 1 second; Broadway describes at least 3 seconds and a rapid switch. These are practical instructions, not validated universal cut-offs. 7 14
On swinging the light to the more affected afferent side, both pupils may constrict less or relatively dilate. A relative afferent pupillary defect (RAPD) supports asymmetric optic-nerve or substantial retinal dysfunction; it is not specific proof of optic neuritis and does not itself cause anisocoria. 7
Symmetric bilateral disease may have no RAPD; a marked field defect can produce RAPD despite good central acuity. A historical series found mild afferent defects in 4 of 45 amblyopic people, 3 seeing better than 20/100, so “only extremely dense amblyopia” is not a reliable rule. A new defect still needs a suitable examination. 2 7 8
Functional visual disorder requires positive evidence of visual function incompatible with the reported deficit, interpreted within a suitable ocular and neurological assessment. Lack of RAPD or an unrevealing scan alone does not establish it, does not prove intentional symptoms, and does not exclude coexisting organic disease. 1 2
05Examine the disc and investigate true swelling
Assess disc shape/tilt, pallor, margins and swelling, vessel course and calibre, haemorrhages, peripapillary atrophy, pigment and cotton-wool spots. Optical coherence tomography (OCT) adds structural information but does not replace examination or exclude early/retrobulbar disease with a normal result. 14
Disc swelling has several causes; papilloedema specifically implies raised intracranial pressure. Confirm the finding and assess blood pressure, vision, formal fields and the fundus, then urgently investigate the cause. The cited adult pathways place appropriate brain imaging including venography before lumbar puncture when safe and indicated, excluding mass, venous thrombosis and contraindications; BMI or contraception alone does not diagnose IIH. 3 9
06Use confrontation findings with protocol limits
Ask whether parts of the examiner’s face are missing or blurred, then test quadrants with static one/two fingers or a moving red target as described. Maintain fixation and test each eye appropriately; these methods are different, and detailed quantitative perimetry complements them without delaying emergency assessment. 14
Kerr’s prospective study included 301 eyes from 163 people, with masked examiners and randomized test order against automated perimetry. Kinetic red-target sensitivity/specificity were 74.4%/93.0%; combined with static finger-wiggle they were 78.3%/90.1%. This contextualises the source’s about 74%/almost 80%, but the combination was not static finger-counting. Full protocols, confidence intervals and within-person analysis remain unread. 4
Shahinfar’s study used one eye each from 72 people and moving fingers: sensitivity was 90% in 10 hemianopia cases and 51% in 35 arcuate cases. Overall 63% of abnormal fields and 38% of abnormal quadrants were detected, excluding the central 15°. Small selected subgroups and defect density limit generalisation; these results cannot be mixed into Kerr’s protocol or treated as universal accuracy. 6
07Apply all findings to the four teaching cases
Case1: A 38-year-old woman has headache, bilateral blur and bumps into objects, with 6/6 acuity in both eyes, mildly reduced colour and no RAPD. A bitemporal field defect localises concern to the chiasmal region and prompts appropriate imaging; it does not by itself identify the lesion or prove compression. 14
Case2: A 20-year-old woman develops right visual decline over 1 week with mild headache, RE 6/18, reduced right colour, a right RAPD and normal fundus. Retrobulbar optic neuritis is a working diagnosis requiring assessment including appropriate MRI; “the patient sees nothing, the doctor sees nothing” illustrates the hidden lesion, not literal blindness or proof of a specific cause. 7 14
Case3: The same 20-year-old presentation and RE 6/18 are described, but no RAPD is detected. The original functional-loss conclusion is not established: demonstrate positive preserved-function/inconsistency findings and assess ocular/neurological alternatives; do not cancel indicated urgent imaging solely because RAPD is absent. Functional and organic disease can coexist. 1 2
Case4: A 21-year-old woman has severe headache, pulsatile tinnitus, unusual vision, nausea, high BMI and oral contraceptive use. Acuity is 6/6 in both eyes, colour normal and RAPD absent, but bilateral papilloedema makes urgent hospital assessment necessary. These reassuring functional findings do not establish safety or a diagnosis of IIH. 3 9 14
In case4, investigate pressure and visual risk, then brain imaging with venography to exclude secondary causes including cerebral venous thrombosis before a safe indicated lumbar puncture. Continue clinical monitoring and cause-directed care; high BMI or contraception must not substitute for exclusion of an alternative cause. 3 9
What are the main learning points of this lecture?
The chapters connect findings, meaning and next steps. Check diagnosis, alternatives and source limits against the individual clinical findings.
Which findings require urgent assessment?
Rapid visual deterioration, severe pain, marked inflammation, pressure rise or suspected infection/neurological disease require urgent assessment. Apply the topic-specific warning signs and clinical context.
References and access status
- 1Management of Functional Vision Disorders
Prior review028 access record explicitly reused and read this turn; see evidence.md for exact sections and new abstract checks. Whole reports/supplements not newly read.
- 2Functional Vision Disorders in adults: A paradigm and nomenclature shift for ophthalmology
Prior review028 access record explicitly reused and read this turn; see evidence.md for exact sections and new abstract checks. Whole reports/supplements not newly read.
- 3Idiopathic intracranial hypertension: consensus guidelines on management
Prior review028 access record explicitly reused and read this turn; see evidence.md for exact sections and new abstract checks. Whole reports/supplements not newly read.
- 4Diagnostic accuracy of confrontation visual field tests
Prior review028 access record explicitly reused and read this turn; see evidence.md for exact sections and new abstract checks. Whole reports/supplements not newly read.
- 5EMA/PRAC semaglutide NAION safety communication 2025
Prior review028 access record explicitly reused and read this turn; see evidence.md for exact sections and new abstract checks. Whole reports/supplements not newly read.
- 6Confrontation visual field loss as a function of decibel sensitivity loss on automated static perimetry
Prior review028 access record explicitly reused and read this turn; see evidence.md for exact sections and new abstract checks. Whole reports/supplements not newly read.
- 7How to test for a relative afferent pupillary defect (RAPD)
Prior review028 access record explicitly reused and read this turn; see evidence.md for exact sections and new abstract checks. Whole reports/supplements not newly read.
- 8Afferent pupillary defects in amblyopia
Prior review028 access record explicitly reused and read this turn; see evidence.md for exact sections and new abstract checks. Whole reports/supplements not newly read.
- 9Diagnosis, treatment and monitoring of idiopathic intracranial hypertension: Consensus recommendations of the Austrian IIH network (AN4IH)
Prior review028 access record explicitly reused and read this turn; see evidence.md for exact sections and new abstract checks. Whole reports/supplements not newly read.
- 10DOG/RG/BVA S2e retinale arterielle Verschlüsse, Version 7.10.2022
Prior review028 access record explicitly reused and read this turn; see evidence.md for exact sections and new abstract checks. Whole reports/supplements not newly read.
- 11Digital Color Vision Testing in Optic Neuropathy: Are Smartphone Apps Ready for Clinical Use?
Prior review028 access record explicitly reused and read this turn; see evidence.md for exact sections and new abstract checks. Whole reports/supplements not newly read.
- 12Comparison of Ishihara Booklet with Color Vision Smartphone Applications.
Prior review028 access record explicitly reused and read this turn; see evidence.md for exact sections and new abstract checks. Whole reports/supplements not newly read.
- 13iPad colour vision apps for dyschromatopsia screening.
Prior review028 access record explicitly reused and read this turn; see evidence.md for exact sections and new abstract checks. Whole reports/supplements not newly read.
- 14Original exported review038 visual-loss lecture
Whole actual original038 export, both tables, four cases and wrapper read. Recording and Haya Razzouk attribution unchecked.
- 15DVLA visual disorders: assessing fitness to drive
Actual indexed selected driver-notification requirement read; whole licensing manual and German law not appraised.
- 16GMC confidentiality and fitness to drive
Actual indexed selected disclosure guidance read; direct subpage redirected to inaccessible queue. Not whole guidance or individual legal advice.
Original lecture link
For patients
Visual loss can come from the eye, optic nerve or visual pathways. Examination combines your symptoms with several tests; one normal result is not the whole answer.
Tell the clinician about timing, medicines, past eye problems and general health. Do not assume that new symptoms come from an old diagnosis or change medication without assessment.
Seek immediate help for sudden deterioration, severe pain, weakness, speech disturbance or a new field defect. Keep the planned follow-up.
Sudden visual loss, a new field defect, severe headache, neurological symptoms, GCA concern or papilloedema need urgent medical assessment.